MicroRNA-29a,b,c as a Tumor Suppressor and Sensitizing Agent for Chemotherapy
OwnerPreethi H. Gunaratneinventor
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of improving a therapeutic response to a cancer treatment, in a subject, the method comprising administering an effective amount of an agent that enhances the expression of microRNA 29 or an agent that mimics the effects of microRNA 29. Further provided is a method of treating a cancer in a subject in need of such treatment comprising the step of administering an effective amount of a microRNA 29 or an agent that enhances the expression of microRNA 29.
Claims25
A method of providing a prognosis for ovarian cancer in a subject, comprising the steps of:
- obtaining a biological sample from said subject;
- and
- testing said biological sample to determine whether or not microRNA 29 is under-expressed in said sample, relative to the expression of microRNA 29 in a control sample, whereby the under-expression of microRNA 29 in said biological sample indicates that a tumor in said subject is resistant to a chemotherapy.
A method of improving a therapeutic response to a cancer treatment, in a subject, the method comprising administering an effective amount of an agent that enhances the expression of microRNA 29 or an agent that mimics the effects of microRNA 29.
A kit for determining a chemotherapy response in a patient with a cancer, said kit comprising:
- a) a oligonucleotide complementary to microRNA 29;
- and b) optionally, reagents for the formation of the hybridization between said oligonucleotide and said microRNA 29.
A pharmaceutical composition for improving a tumor response to chemotherapy, said composition comprising an effective amount of microRNA 29 or an agent that enhances the expression of microRNA 29.
A method of treating a cancer in a subject in need of such treatment comprising the step of administering an effective amount of a microRNA 29 or an agent that enhances the expression of microRNA 29.
Dependencies are inferred from the claim text.